ARTICLE | Company News
Cornerstone Therapeutics, Oscient deal
September 7, 2009 7:00 AM UTC
Cornerstone said the U.S. Bankruptcy Court for the District of Massachusetts approved its previously announced acquisition of Factive gemifloxacin mesylate from Oscient. The deal will close "promptly...